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WU polyomavirus (WUPyV) was detected in a bone marrow 
transplant recipient with severe acute respiratory distress syn-
drome who died in 2001. Crystalline lattices of polyomavirus-
like particles were observed in the patient’s lung by electron 
microscopy. WUPyV was detected in the lung and other tis-
sues by real-time quantitative PCR and identified in the lung 
and trachea by immunohistochemistry. A subset of WUPyV-
positive cells in the lung had morphologic features of macro-
phages. Although the role of WUPyV as a human pathogen 
remains unclear, these results clearly demonstrate evidence 
for infection of respiratory tract tissues in this patient.
Polyomaviruses are small, circular, double-stranded DNA viruses. Infection with BK polyomavirus 
(BKPyV) or JC polyomavirus causes substantial illness 
and death in immunocompromised populations, including 
transplant recipients and HIV patients (1). Infection with 
either virus is typically asymptomatic unless the host is im-
munocompromised. Since 2007, a total of 11 additional hu-
man polyomaviruses have been discovered. Two of these 
viruses (Merkel cell carcinoma polyomavirus and tricho-
dysplasia spinulosa–associated polyomavirus) have also 
been implicated as human pathogens in the context of im-
munosuppression (2,3); the former causes Merkel cell car-
cinoma, a rare but aggressive skin cancer (3), and the latter 
is associated with trichodysplasia spinulosa, a rare skin dis-
ease seen in transplant recipients (2). Several of the other 
new human polyomaviruses (e.g., human polyomavirus 9 
and New Jersey polyomavirus) were also initially identified 
in immunocompromised patients (4,5).
In 2007, WU polyomavirus (WUPyV) was discovered 
in a child in Australia with pneumonia (6). Although the vi-
rus has yet to be implicated in human disease, epidemiologic 
studies have shown that 69%–80% of persons (7–9) are se-
ropositive for this virus; infection probably occurs during 
early childhood. In addition, viral DNA has been detected in 
blood, feces, respiratory tract secretions, tonsils, and cere-
brospinal fluid (10). Although these studies have contribut-
ed to a better understanding of WUPyV, only 1 has explored 
the in vivo tropism of the virus or described the detection 
of viral antigen in tissue (11). That study determined that 
WUPyV was present in epithelial cells from a bronchoal-
veolar lavage from a lung transplant recipient with Job syn-
drome. A complete understanding of the types of cells and 
tissues in which the virus replicates is critical for identifying 
potential diseases with which it may be associated. Howev-
er, the propensity for viruses of the family Polyomaviridae 
to cause disease only within the context of immunosuppres-
sion makes disease association particularly challenging. We 
describe molecular characterization and immunohistologic 
and microscopic localization of WUPyV in tissues from a 
deceased patient who had had viral pneumonitis.
Materials and Methods
The Case
In January 2001, a 27-month-old girl was admitted to an 
upstate New York area hospital for a 5/6 human leukocyte 
antigen–matched cord blood transplant from an unrelated 
donor. The patient had been born by normal vaginal deliv-
ery after 40 weeks of gestation. Her medical history includ-
ed leukocytosis at 3 months and splenomegaly at 6 months 
of age. Refractory juvenile myelomonocytic leukemia was 
diagnosed when she was 16 months of age, and she un-
derwent splenectomy in September 2000. She had multiple 
infections before 2 years of age, including otitis media, a 
central vein catheter infection, and a urinary tract infection. 
She also demonstrated failure to thrive, developmental de-
lay, mild pulmonic stenosis, and gastroesophageal reflux.
Three weeks after the bone marrow transplant, the child 
experienced fever; diarrhea; hepatomegaly; and erythema 
on her face, palms, and soles. She was evaluated for graft 
versus host disease, viral exanthema, and drug eruption. The 
results of skin biopsies performed at 4 weeks after transplan-
tation ruled out graft versus host disease and drug eruption. 
A rectosigmoid biopsy performed at the same time as the 
skin biopsies showed mild stromal edema but was negative 
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for adenovirus and cytomegalovirus by immunohistochem-
istry (IHC) staining. Throughout the course of the patient’s 
hospitalization, adenovirus was intermittently isolated from 
her feces and urine and influenza B virus was detected in her 
nose and throat. PCR testing of the blood for cytomegalovi-
rus was consistently negative. Treatment included cyclospo-
rine; Solu-medrol (Pharmacia & Upjohn LLC, New York, 
NY, USA); intravenous immunoglobulin; ribavirin; Zosyn 
(Pfizer Inc., New York, NY, USA); Flagyl (Pfizer Inc.); 
Flutamine (Schering-Plough, Kenilworth, NJ, USA); Tami-
flu (Roche Pharmaceuticals, Nutley, NJ, USA); Demerol 
(Sanofi-Aventis U.S. LLC, Bridgewater, NJ, USA); Zofran 
(GlaxoSmithKline, Philadelphia, PA, USA); Phenergan 
(Wyeth, Madison, NJ, USA); Tylenol (Johnson & Johnson, 
New Brunswick, NJ, USA); albuterol; isradipine; Spirono-
lactone (Mylan Pharmaceuticals, Morgantown, WV, USA); 
hemotransfusion; and platelet transfusion. Despite this ag-
gressive therapy, the patient’s condition continued to dete-
riorate. On March 1, 2001, the patient was transferred to the 
pediatric intensive care unit because of respiratory failure. 
Chest radiographs revealed pulmonary edema. Her condition 
was stabilized 2 days later, but severe acute respiratory dis-
tress syndrome and distended abdomen developed on April 
1. Treatment was continued and mechanical ventilation was 
added. A radiograph taken on April 15 (≈11 weeks after 
transplantation) revealed free air in the abdominal cavity, 
but the source was not identified. The patient died later that 
day; the probable cause of death was viral pneumonitis. An 
autopsy was performed.
Electron Microscopy
Lung tissues were fixed in formalin and then postfixed in 
2.5% glutaraldehyde/0.1 mol/L Millonig phosphate buffer 
before processing into epoxy resin for sectioning and film 
photography. Microscopic examination was performed 
with a Hitachi 7100 transmission electron microscope (Hit-
achi High-Technologies Science America Inc., Northridge, 
CA, USA). 
IHC 
IHC was performed as described previously (11). In brief, 
formalin-fixed paraffin-embedded blocks of tissue were 
deparaffinized, rehydrated, and treated with 3% hydro-
gen peroxide. Antigen was retrieved, and samples were 
blocked in 1.5% normal horse serum. A mouse monoclonal 
antibody against viral protein (VP) 1 from WUPyV (WU-
VP1) (NN-Ab06) or an isotype-matched control antibody 
(mouse IgG2b; BD Biosciences, San Jose, CA, USA; no. 
557351) was incubated overnight. After incubation with 
the biotinylated antimouse IgG secondary antibody (Vec-
tor BA-2000; Vector Laboratories, Inc., Burlingame, CA, 
USA), slides were developed by using the Vectastain ABC 
kit (Vector Laboratories, Inc.; no. PK-6100) and DAB 
(Vector Laboratories, Inc.; no. SK-4100), counterstained 
with hematoxylin, dehydrated, cleared, and mounted.
Double IHC 
The double IHC (dIHC) staining protocol was similar 
to the regular IHC protocol with the addition of several 
steps. After the blocking step, slides were incubated with 
NN-Ab06 and then the secondary antibody. Development 
was accomplished by using the ABC kit and ImmPACT 
SG (Vector Laboratories, Inc.; no. SK-4705). Tissues were 
blocked with avidin and biotin (Vector Laboratories, Inc.; 
no. SP-2001) then with 1.5% normal horse serum. Slides 
were incubated in the second primary antibody against 
CD68 (Dako, Glostrup, Denmark; no. M081401) and then 
in biotinylated antimouse IgG secondary antibody. The 
second set of staining was developed by using the ABC kit 
and 3,3′-diaminobenzidine, followed by dehydration. For 
the MUC5AC dIHC assay, staining was first performed 
with the monoclonal antibody against MUC5AC (Thermo 
Fischer, Rockford, IL, USA; no. MA1–38223), which 
was developed with 3,3′-diaminobenzidine. Staining with 
NN-Ab06 and development with SG substrate (Vector 
Laboratories, Inc.) followed the blocking steps. Tissues 
stained by using the dIHC protocol were not counter-
stained. Control staining with an IgG2b isotype antibody 
(for NN-Ab06) and an isotype antibody against IgG1 (for 
the CD68 and MUC5AC antibodies) was also performed.
Nucleic Acid Extraction and PCR
DNA was extracted from formalin-fixed paraffin- 
embedded samples by using the QIAGEN BioRobot M48 
workstation and MagAttract DNA Mini Kit (QIAGEN, 
Valencia, CA, USA). A quantitative real-time PCR (qPCR) 
assay for detection and viral load estimation of WUPyV/
KIPyV was developed and used to screen the extracted 
DNA. Primer and probe sequences for the qPCR assay 
were forward 5′-GTAGCTGGAGGAGCAGAGGC-3′; 
5′-CACCAAGRGCAGCTAARCCTTC-3′; and probe 
5′-CTGGWTCTGGAGCTGCMATAGCWACTGGT-3′. 
qPCRs were performed by using iQ Supermix reagents 
(Bio-Rad, Hercules, CA, USA); each 25-µL reaction 
mixture contained 0.6 µmol/L forward primer, 0.3 µmol/L 
reverse primer, 0.1 µmol/L probe, and 5 mL nucleic acid 
extract. Amplification was conducted on an iCycler iQ 
Real-time Detection System (Bio-Rad). Thermocycling 
conditions consisted of 3 min at 95°C for activation of the 
iTaq DNA polymerase and 45 cycles of 15 s at 95°C and 1 
min at 60°C. Extracts were also tested for human bocavirus 
(HBoV) by using a previously described qPCR assay (12). 
For distinguishing between WUPyV and KIPyV, conven-
tional PCR and sequencing was performed by using prim-
ers forward 5′-GGAGCTGTAYAGAATGGAAAC-3′ and 
reverse 5′-TTCATCCAAYAGTGGAATTG-3′.
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Complete Genome Sequencing
Multiple segments of the WUPyV genome were ampli-
fied and sequenced by using overlapping primer sets 
(Table 1) designed from reference strain WU/Wuerz-
burg/02/07 (GenBank accession no. EU711057.1). Am-
plicons were directly sequenced by using the ABI Prism 
BigDye Terminator Cycle Sequencing Ready Reaction 
Kit, version 3.1, on an ABI 3130 XL DNA Sequencer 
(both from Applied Biosystems, Carlsbad, CA, USA). 
The complete genome sequence for isolate Roches-
ter-7029 is available through GenBank under accession 
no. FJ794068.
Results
The most remarkable gross autopsy findings were bilat-
eral pulmonary consolidation, acute tracheobronchitis, 
hepatomegaly with cholestasis, deep mucosal ulcerations 
throughout the small bowel, and prominent generalized 
lymphadenopathy. The most notable pathologic finding 
was heavy hemorrhagic foci in the lungs. Microscopic 
examination of the lungs confirmed the presence of in-
terstitial emphysema with profound hemorrhage in the 
right upper, right middle, left upper, and left lower lobes. 
Multiple smudge cells and cells with Cowdry type A nu-
clear inclusions were identified inside reactive bronchial 
epithelium from both lungs. Similar inclusions were seen 
in epithelium of the trachea, bile duct, renal tubules, and 
urinary bladder. Small bowel mucosa revealed multifo-
cal ulcerations and scattered inclusion-bearing cells in 
the epithelium. Findings after immunoperoxidase staining 
were negative for cytomegalovirus, adenovirus, influenza 
virus, human papillomavirus, respiratory syncytial virus, 
and simian virus 40, and in situ hybridization was nega-
tive for Epstein-Barr virus. Attempts to culture virus from 
the lung, liver, gastrointestinal tract, and lymph node tis-
sues were unsuccessful. Gram-stained sections of lung, 
liver, and lymph node showed >25 neutrophils per low-
power field without presence of organisms. Coagulase-
negative Staphylococcus spp. grew from a blood culture 
(<30 CFU/mL) and culture of the gastrointestinal tract. 
No strictly anaerobic growth was observed.
Electron micrographs of the lungs showed viral par-
ticles in the nuclei, many in para-crystalline arrays (Fig-
ure 1). The particles were 30.4–34.7 nm (mean 32.1 nm) 
in diameter. The diameter was less than the conventional 
diameter for polyomaviruses (45 nm), but the size of viral 
particles can vary according to the method of fixation and 
embedding (14). In addition, previously published electron 
microscopy findings for BKPyV particles indicated mea-
surements of 30–50 nm (15). Despite the presence of viral 
particles indicative of polyomavirus, IHC on lung tissue 
with a primary antibody against simian virus 40, which 
is known to cross-react with BK and JC polyomaviruses, 
was negative. IHC for adenovirus and respiratory syncy-
tial virus was also negative. Although electron microscopy 
indicated a probable viral infection in the patient’s lungs, 
because of the negative IHC results, no further testing was 
performed at that time.




Table 1. Primers used to sequence WU polyomavirus in lung 
tissue from a child with acute respiratory illness 









WU seq F1 AGCTAAGCATGATTGACAGTGTG 
WU seq R1 CAGACTCAACGGAGATGTCACA 
WU seq F2 TCACTGTTATGTGCAGGAATGT 
WU seq R2 ACAGCAAGCAATATGCCCATC 
WU seq F3 TATTGGTGCTACCGTCTCGAAC 
WU seq R3 GTGGATGGACTGGATATTAAGTC 
WU seq F4 ATATATACAGCTTTAGCAGCAGATC 
WU seq R4 CTTACTTGTTCAACTATAGCATTTACTG 
WU seq F5 CAGTAGTTAATAGAGCAGTTAGTGAAGA 
WU seq R5 TAGAAATGTCACTGTTTAGCTCTTC 
WU seq F6 GATGGCTTTAATGCACTTAGTGATG 
WU seq R6 GTAGCACACAGTAGTATCAGCATCAG 
WU seq F7 ATTAGTAGCCCACTTAAAACTGCTG 
WU seq R7 TCTGCCACCCATGATTCAATG 
WU seq F8 GTTTATTCCAGTTCTGAAACACC 
WU seq R8 GCAAATGAGACAAATTACTGGTTG 
WU seq F9 CTTTATAAGCAGGTGTTTAATAAGC 
WU seq R9 TAAAAGAAAGTCTGGATAAAACTCC 
WU seq F10 TTCTTTCCAATACACAACTTTAGC 
WU seq R10 GGTAAAACAACTGTTGCTGCT 
WU seq F11 CTCCTACTTGACCTTTTACATCTTC 
WU seq R11 CAACTCATAATAGACTTCATATGGAAC 
WU seq F12 TCTTCTAGCTAATAAATCTTCTCTGG 
WU seq R12 GTAATACATACCACCAAAGAAAAGG 
WU seq F14 CAGCACTAACTCTATGTCTAAAAGG 
WU seq R14 GGTGCTATAGAGAGTGGTTTGG 
WU seq F15 CTCATTACATCTTAGTTCTTCTTCC 
WU seq R15 AAGAATTTCATCCTGACAAAGG 
WU seq F16 TCTACCTGTGAAGAGCTCCACAC 
WU seq R16 CACATTCCTGCACATAACAGTG 
WU seq F17 CTAAGCATGATTGACAGTGTGG 
WU seq R17 TGATAGTGCCTCTGCTCCTC 
AG0058 GCTCCACCTTGTGGCTGCTA (6) 
AG0036 GCATTTACTGGGTCAGATTCC (6) 
AG0035 TGCATTCTACCTGTGAAGAGC (6) 
WU seq F6.5 GTACCACTGTCAGAAGAAACAGAG 
WU seq F7.5 GATGTGCTAGGACTTGCTCC 
WU seq R9.5 CCTCCAGGTATTGTAACAATGAATG 
WU-C-4824-F GGCACGGCGCCAACT (13) 
WU-C-4898-R CCTGTTGTAGGCCTTACTTACCTGTA (13) 
WU 4422R GAAATGCCTAAATCTCCTGGAG 
WU 4341F GTGTTGCCTGTGAACATTGTG 
WU 4810R AGACTGGGACATATGCTTAAAGG 
WU 4571F GCTTACCTGGTTAAGCCAAC 
WU 4945R GTGAAGTAGAAGAAGAAGTAAATCA 
WU 5225R AAAGCCTCAACTTTCTGAACTA 
WU 783R AAGCTCAGGTACTTTTGTTAGTACAG 
PyVseq 844F GGAGCTGTAYAGAATGGAAAC 
PyVseq 2419R TTCATCCAAYAGTGGAATTG 
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WUPyV in the Lungs
The recent discoveries of HBoV, another small, cir-
cular DNA virus, in 2005 and 2 new polyomavi-
ruses, WU and KI (KIPyV), in 2007, in the respira-
tory tracts of children with acute respiratory illness 
prompted us to investigate the involvement of these 
viruses in this case. DNA extracted from formalin-
fixed paraffin-embedded lung, liver, kidney, and gas-
trointestinal tissues was tested by qPCR for WUPyV, 
KIPyV, and HBoV. All 4 tissues were positive for 
WUPyV, whereas KIPyV and HBoV were not detected 
in any of the tissues. Virus loads estimated by qPCR 
were substantially higher in samples from the lung 
(cycle threshold 16.6) than in samples from the liver, 
kidney, and gastrointestinal tract (cycle threshold 30.2–
30.8; Table 2). The entire WUPyV genome (designated 
Rochester-7029, GenBank accession no. FJ794068) was 
subsequently sequenced from lung tissue to 4× coverage 
(each base sequenced independently 4 times) by using 
multiple primer sets and found to be 5,306 bp. Compared 
with 79 complete WUPyV genome sequences avail-
able in GenBank, nucleotide identity scores for Roch-
ester-7029 ranged from 0.970 to 0.985. Compared with 
the reference sequence, Rochester-7029 had 8 single-nu-
cleotide polymorphisms, 5 of which were in coding re-
gions. Two of these 5 were synonymous mutations. We 
predicted an amino acid change in VP2 and VP3 from 
glutamic acid to glutamine at positions 250 and 107, 
respectively. We also predicted amino acid changes in 
large T-antigen: glutamine to glutamic acid at position 
134 and isoleucine to leucine at position 594. Of note, 
the Rochester-7029 genome contained a 77-bp termi-
nal duplication in the large T-antigen as compared with 
the reference WUPyV genome, which was not predicted 
to have any effect on the size or sequence of the trans-
lated protein because it was located 3′ to the T-antigen 
stop codon.
After detection of WUPyV in the patient’s tissues by 
real-time qPCR, WUPyV-specific IHC with a previously 
described assay (11) was performed on available tissues 
(lung, liver, kidney, and gastrointestinal tract) to deter-
mine whether WU-VP1 antigen was also present (Fig-
ure 2). Liver, kidney, and gastrointestinal tissues were 
all negative (Table 2). Staining was observed in the lung 
(Figure 2, panels A, C) and the trachea (Figure 2, panel 
E), but no staining was observed in serial sections stained 
with an isotype control antibody (Figure 2, panels B, D, 
F). Serial sections stained with no primary or secondary 
antibodies were also negative (not shown). Overall, we 
saw 3 patterns of staining in the lung. In some cells, WU-
VP1 staining was primarily in the nucleus. In others, the 
perimeter of the nucleus was strongly positive. And in 
others, the staining was diffuse, making it difficult to dis-
cern its position within cells. Of note, the tracheal staining 
was within a submucosal gland, where WUPyV tropism 
has not been previously described.





Table 2. Summary of virus findings in tissue samples from child with acute respiratory illness* 
Study Lung Liver Kidney Gastrointestinal 
Intranuclear inclusions Positive Positive Positive Positive 
Electron microscopy Positive Not performed Not performed Not performed 
WUPyV/KIPyV qPCR Positive (16.6) Positive (30.8) Positive (30.4) Positive (30.2) 
WUPyV PCR and sequencing Positive Positive Positive Positive 
KIPyV PCR and sequencing Negative Negative Negative Negative 
WUPyV IHC Positive Negative Negative Negative 
HBoV qPCR Negative Negative Negative Negative 
*Numbers in parentheses indicate cycle thresholds from qPCR. HBoV, human bocavirus; IHC, immunohistochemistry; KIPyV, KI polyomavirus; qPCR, 
real-time quantitative PCR; WUPyV, WU polyomavirus. 
 
Figure 1. Electron micrographs of polyomavirus-like particles in lung from a child with fatal acute respiratory illness. A) Low-power view 
of a nucleus displaying multiple electron dense crystalline arrays. Scale bar indicates 0.5 µm; original magnification ×10,000.  
B) Higher-power magnification of nucleus in panel A. Scale bar indicates 100 nm; original magnification ×30,000. C) Large cluster of 
putative polyomavirus virions. Scale bar indicates 250 nm; original magnification ×20,000.
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WU-VP1 in CD68-Positive Cells
A recent article described detection of WU-VP1 in epi-
thelial cells obtained from a bronchoalveolar lavage of a 
lung transplant recipient with Job syndrome (11). We an-
ticipated that some WUPyV-positive cells in lung tissues 
of the patient reported here were also epithelial cells, but 
we did not explicitly confirm this suspicion because of the 
limited amount of lung tissue available. Instead we chose to 
explore additional hypotheses regarding potential tropisms 
of WUPyV because of our recent detection of KIPyV in 
CD68-positive cells (16). CD68 is a glycoprotein present 
on monocytes and macrophages. We performed dIHC test-
ing by using the monoclonal antibody against WU-VP1 
(NN-Ab06) and a monoclonal antibody against CD68, 
which primarily labels macrophages and monocytes. Cells 
positive for both WU-VP1 and CD68 were detected within 
the patient’s lung tissue (Figure 3). In addition, the cell 
shown in Figure 3, panel B (arrow) is morphologically con-
sistent with a foamy macrophage, a specific morphotype of 
macrophage that is laden with lipid droplets in the cyto-
plasm (17). A serial section stained with isotype-matched 
antibodies (IgG2b for NN-Ab06 and IgG1 for the anti-CD68 
antibody) was negative (not shown). In a recent study, 
KIPyV was also detected in a foamy macrophage (16). 
WU-VP1 Antigen in Association with  
Mucin-Producing Cells
The initial IHC staining of tracheal tissue revealed posi-
tive cells within a submucosal gland. MUC5AC is the 
principal mucin produced by goblet cells, and MUC5B 
is produced by submucosal glands (18). We developed 
2 dIHC assays: NN-Ab06 and a monoclonal antibody 
against MUC5AC and NN-Ab06 and a polyclonal an-
tibody against MUC5B. Each assay was performed on 
control cell pellets (not shown). The MUC5AC dIHC as-
say yielded clearer staining, so we chose to apply this as-
say to the tracheal tissue from the patient. We detected 
WU-VP1–positive cells in association with a cluster of 
cells showing MUC5-AC positivity (Figure 4). It is un-
clear whether the 2 antigens colocalize to the same cell. 
WU-VP1–positive cells were also seen separate from 
MUC5AC-positive cells, suggesting that a subset of vi-
rus-positive cells do not produce mucin. We found 2 such 
areas in the tracheal tissue.
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Figure 2. Immunohistochemical 
detection of WU polyomavirus 
viral protein 1 in respiratory 
tract of a child with fatal acute 
respiratory illness. Human lung 
tissue at original magnification 
of ×200, stained with a 
monoclonal antibody against 
WU polyomavirus viral protein 
1 (designated NN-Ab06) (A, C) 
or an isotype control antibody 
(B, D). Human tracheal tissue 
at original magnification of 
×200, stained with NN-Ab06 (E) 
or an isotype control antibody 
(F). The middle panels show 
insets from panels A, C, and E 
(dotted boxes) at higher original 
magnifications (×600).
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Discussion
We describe a case of viral pneumonitis in a bone marrow 
transplant recipient who died in 2001. Before her death, in-
fluenza and adenovirus were identified from the patient. 
Although samples from the patient were initially tested for 
several viruses by IHC and culture, no agent was identified. 
Subsequent work since 2007 showed that multiple tissues 
from this patient were positive for WUPyV by real-time PCR 
and IHC, but the same tissues were negative for KIPyV and 
HBoV by PCR. To date, WUPyV has been the only virus de-
tected in tissue samples from this patient. Crystalline lattices 
of polyomavirus-like particles were seen in the lung, which 
substantiated the high virus titers measured by qPCR. Collec-
tively, these observations suggest a potential pathogenic role 
for WUPyV infection in this case. However, we cannot rule 
out the possibility that WUPyV infection was simply opportu-
nistic in this severely immunocompromised patient.
Analysis of samples from this patient provided novel 
insights into fundamental properties of WUPyV infection 
in vivo. In the lungs, we detected WUPyV antigen in CD68-
positive cells (probably of the macrophage/monocyte lin-
eage) by immunohistochemistry. WUPyV is most closely 
related to KIPyV, and the viruses share many similarities, 
including an apparent tropism for CD68-positive cells (16). 
Other polyomaviruses have also been detected in cells of 
the monocytic lineage (16). We do not believe that this de-
tection represents phagocytosis of other WUPyV-infected 
cell types because WU-VP1, a late-expressed protein, was 
detected in the nucleus of CD68-positive cells, suggesting 
an infection in this patient. Granted, we did not prove that 
infectious particles were produced.
WU-VP1 was also detected in close proximity to 
MUC5AC-positive cells in tracheal tissue. The detec-
tion of WUPyV in tracheal tissue was unexpected and 
expands the known tissue tropism of the virus. As previ-
ously mentioned, MUC5AC is a mucin primarily produced 
by goblet cells in the airway. Several viruses in glandular 
cells in the trachea have been described: adenovirus has 
grown in primary cultured peribronchial submucosal gland 
cells (19); rhinovirus has grown in human respiratory sub-
mucosal gland cells (20); severe acute respiratory syndrome 
coronavirus antigen and RNA have been detected in tra-
cheal/bronchial serous gland epithelium (21); and BKPyV 
has been shown to replicate in salivary gland cells (22,23).
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Figure 3. Detection of WU 
polyomavirus viral protein 1 
in CD68-positive cells from a 
child with fatal acute respiratory 
illness. Lung tissue stained 
with NN-Ab06 (blue) and a 
monoclonal antibody against 
CD68 (brown). A) Tissue 
at original magnification of 
×400. B) Closer view of cell 
from panel A consistent with 
a foamy macrophage (arrow). 
Original magnification ×1,000. 
C) Closer view of cells from 
panel A. Original magnification 
×1,000. D) Different field of 
the tissue section with another 
double-positive cell. Original 
magnification ×1,000.
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In conclusion, WUPyV was detected by multiple 
methods in the lung of a bone marrow transplant recipient 
who had viral pneumonitis at the time of death. Tracheal 
tissue from this patient was also positive for WU-VP1. 
Viral antigen was specifically detected in CD68-positive 
cells and in close association with MUC5AC-positive 
cells within a tracheal submucosal gland. The role of 
WUPyV as a human pathogen remains unclear, although 
the evidence for an infection of the respiratory tract in this 
patient is strong. This study expands our understanding of 
WUPyV biology and tropism beyond detection of virus in 
body fluids.
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